- Press Releases
- Events & Presentations
- Corporate Governance
- Shareholder & Stock Info
- Financial Reports
- Financial calendar
In accordance with the Companies Act, is the shareholders’ influence in Immunicum exercised at the general meeting, which is the company’s highest ranking decision-making body. At the annual general meeting, the shareholders decide upon central matters, including amendments of the articles of association, confirmation of the income statements and balance sheets, possible dividends and distribution of the company’s profit or loss, election of board members and auditors and decisions regarding remuneration to the same, and decision regarding discharge of liability for the board of directors and the managing director.
In accordance with the articles of association, the notice of summons to annual general meeting shall be made by announcement in Post- och Inrikes Tidningar and by making the notice of summons available on the company’s website. Simultaneously with the notice, the company shall by way of announcement in Dagens Industri inform that notice has been made. Notice of summons to the annual general meeting and an extraordinary general meeting where a matter of amendment of the articles of association shall be resolved shall be made at earliest six (6) and not later than four (4) weeks prior the meeting. Notice of summons to other extraordinary general meetings shall be made at earliest six (6) and not later than three (3) weeks prior to the extraordinary general meeting.
Shareholders recorded in the share register in accordance with the provisions in the Companies Act, and that have given notice of their attendance to the company no later than the day mentioned in the notice, have the right to participate at the general meeting. Such day may not be on a Sunday, any other public holiday, Saturday, Midsummer Eve, Christmas Eve or New Year’s Eve and may not occur earlier than the fifth working day prior to the meeting.
At the annual general meeting, the following matters shall be addressed:
1. Election of chairman of the general meeting.
2. Preparation and approval of voting register.
3. Presentation and approval of the agenda.
4. Election of one or two persons to check the minutes.
5. Control if the meeting has been duly convened.
6. Presentation of the annual report and the audit report and, if applicable, the consolidated annual report and consolidated audit report.
a) on confirmation of the income statement and balance sheet and, if applicable, the group income statement and group balance sheet.
b) on disposition of the company’s profit or loss according to the adopted balance sheet.
c) discharge of liability for the board of directors and the managing director.
8. Determination of remuneration for the directors of the board of directors and auditors.
9. Election of directors of the board of directors and auditors and, if applicable, deputy auditors.
10. Other matters that are to be addressed at the annual general meeting pursuant to the Companies Act or the articles of association.
Annual general meeting 2018
The annual general meeting 2018 will take place on 10 April 2018.
Shareholders who wishes to have a matter addressed at the general meeting 2018 shall have submitted a written request to the board of directors not later than seven weeks prior to the date of the annual general meeting.
The request shall be sent to: Immunicum AB (publ), Board of directors, Grafiska vägen 2, 412 63 Göteborg.
Notice of summons to attend the annual general meeting of Immunicum AB (publ)
|Notice of summons 2017|
|Proxy Form (Swedish only)|
|Nomination Committee Statement (Swedish only)|
|The board of directors' proposal regarding authorization (Swedish only)|
|The board of directors' proposal regarding guidelines for remuneration to senior executives (Swedish only)|